We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Phase I Study of H5.020CMV.PDGF-β to Treat Venous Leg Ulcer Disease.
- Authors
Margolis, David J.; Morris, Lee M.; Papadopoulos, Maryte; Weinberg, Linda; Filip, Jennifer C.; Lang, Stephanie A.; Vaikunth, Sachin S.; Crombleholme, Timothy M.
- Abstract
Venous leg ulcers are a prevalent nonhealing wound of the lower extremity. Although topically applied growth factors successfully improve wound repair in animal studies, similar studies on humans with venous leg ulcers have not been successful. This study was designed to evaluate the acute safety and biologic feasibility of peri-ulcer injection of a replication-incompetent adenoviral construct expressing platelet-derived growth factor-β (PDGF-β). In this phase I study, we demonstrate the initial safety, feasibility, and biologic plausibility of using H5.020CMV.PDGF-β to treat venous leg ulcer disease.
- Subjects
LEG diseases; CHRONIC wounds &; injuries; INTERMITTENT claudication; WOUNDS &; injuries; PLATELET-derived growth factor; BLOOD proteins
- Publication
Molecular Therapy, 2009, Vol 17, Issue 10, p1822
- ISSN
1525-0016
- Publication type
Article
- DOI
10.1038/mt.2009.169